End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.12 CNY | -1.11% | +1.48% | -11.16% |
Business Summary
Number of employees: 9,223
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chinese Medicines
68.8
%
| 5,557 | 64.7 % | 5,971 | 68.8 % | +7.46% |
Pharmaceutical Business
14.0
%
| 1,417 | 16.5 % | 1,215 | 14.0 % | -14.21% |
Chemical Pharmaceuticals
13.9
%
| 1,270 | 14.8 % | 1,203 | 13.9 % | -5.30% |
Biological Drugs
2.2
%
| 248 | 2.9 % | 190 | 2.2 % | -23.47% |
Chemical Raw Materials
0.7
%
| 71 | 0.8 % | 57 | 0.7 % | -19.67% |
Other Business
0.4
%
| 31 | 0.4 % | 38 | 0.4 % | +22.38% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.7
%
| 8,593 | 100.0 % | 8,635 | 99.7 % | +0.49% |
Overseas
0.3
%
| - | - | 23 | 0.3 % | - |
Managers
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Meng Jiang
BRD | Director/Board Member | 60 | 07-08-16 |
Ai Jian Wang
BRD | Director/Board Member | 70 | 21-06-01 |
Jin Yong Cai
BRD | Director/Board Member | 52 | 06-03-24 |
Kai Jing Yan
CHM | Chairman | 45 | 14-03-27 |
Yong Hong Zhu
BRD | Director/Board Member | 59 | 13-04-23 |
Zheng Liang Ye
CHM | Chairman | 57 | 18-04-15 |
Ai Chun Ju
BRD | Director/Board Member | 51 | 14-04-13 |
Hong Wei Liu
BRD | Director/Board Member | 52 | 95-12-31 |
Liu Xin
BRD | Director/Board Member | 56 | 18-04-15 |
Bin Zhang
BRD | Director/Board Member | 70 | 21-06-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,499,700,130 | 736,727,818 ( 49.13 %) | 5,750,125 ( 0.3834 %) | 49.13 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
IMMUNOTECH BIOPHARM LTD 18.87% | 97,102,571 | 18.87% | 46,278,114 $ |
Company contact information
Tasly Pharmaceutical Group Co., Ltd.
2, Puji River East Road Beichen District
300410, Tianjin
+86 22 2673 6999
http://www.tasly.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.16% | 3.14B | |
+37.15% | 6.12B | |
-16.04% | 4.44B | |
-1.40% | 3.03B | |
+0.12% | 2.57B | |
+38.69% | 1.87B | |
+1.11% | 1.63B | |
-10.34% | 1.62B | |
-12.97% | 1.53B | |
+36.21% | 1.45B |
- Stock Market
- Equities
- 600535 Stock
- Company Tasly Pharmaceutical Group Co., Ltd